PTN - Palatin's gets Orphan Drug status for its treatment for obesity from genetic disorder
2025-03-25 09:26:38 ET
More on Palatin Technologies
- Palatin Technologies, Inc. (PTN) Q2 2025 Earnings Call Transcript
- Palatin Technologies prices 4.69M shares in direct offering
- Seeking Alpha’s Quant Rating on Palatin Technologies
- Historical earnings data for Palatin Technologies
- Financial information for Palatin Technologies